Evrysdi, illustration of tablet bottle form (not a photo of the actual pack)

Illustrative image.

Evrysdi

Risdiplam

Prescription required

$130400.00

0.75mg/ml · 8 × 1 bottle · 3 months supply

BrandBranded medicine· By Roche

$43466.67 per month

How long a supply?

1 month$48900.00 a month
3 months$43466.67 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$489000a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

About Evrysdi

Overview

Evrysdi is a prescription medicine containing risdiplam, supplied in a bottle as a powder for preparation into an oral solution. It is used to treat spinal muscular atrophy (SMA) in children and adults. It works by changing how the SMN2 gene’s instructions are processed to increase production of full-length survival motor neuron (SMN) protein.

What it treats

Spinal muscular atrophy (SMA) in children and adults.

Safety information

Side effects

Common side effects of Evrysdi in people with later-onset spinal muscular atrophy (SMA) include fever, diarrhea and rash. In infantile-onset SMA, common side effects also include upper and lower respiratory tract infections, constipation, vomiting and cough.

Before taking this medicine

The FDA label lists no contraindications for Evrysdi. Caution is needed during pregnancy: based on animal data, it may harm an unborn baby.

Interactions

Evrysdi should not be taken with medicines that are substrates of multidrug and toxin extrusion (MATE) transporters. Ask your doctor whether any of your medicines fall into this group.

Using Evrysdi

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place with the bottle tightly closed, away from direct light and moisture. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label EVRYSDI (RISDIPLAM) POWDER, FOR SOLUTION EVRYSDI (RISDIPLAM) TABLET [GENENTECH, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines